JP2023041861A5 - - Google Patents

Download PDF

Info

Publication number
JP2023041861A5
JP2023041861A5 JP2023014533A JP2023014533A JP2023041861A5 JP 2023041861 A5 JP2023041861 A5 JP 2023041861A5 JP 2023014533 A JP2023014533 A JP 2023014533A JP 2023014533 A JP2023014533 A JP 2023014533A JP 2023041861 A5 JP2023041861 A5 JP 2023041861A5
Authority
JP
Japan
Prior art keywords
hydrogel composition
dehydrated hydrogel
lidocaine
weight
matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023014533A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023041861A (ja
Filing date
Publication date
Priority claimed from PCT/US2018/031654 external-priority patent/WO2018208822A1/en
Application filed filed Critical
Publication of JP2023041861A publication Critical patent/JP2023041861A/ja
Priority to JP2023173522A priority Critical patent/JP2023168587A/ja
Publication of JP2023041861A5 publication Critical patent/JP2023041861A5/ja
Pending legal-status Critical Current

Links

JP2023014533A 2017-05-08 2023-02-02 増大した薬剤負荷および接着のためのナノ構造化ゲルの製剤 Pending JP2023041861A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023173522A JP2023168587A (ja) 2017-05-08 2023-10-05 増大した薬剤負荷および接着のためのナノ構造化ゲルの製剤

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762502872P 2017-05-08 2017-05-08
US62/502,872 2017-05-08
PCT/US2018/031654 WO2018208822A1 (en) 2017-05-08 2018-05-08 Formulation of nanostructured gels for increased agent loading and adhesion
JP2019562349A JP7211974B2 (ja) 2017-05-08 2018-05-08 増大した薬剤負荷および接着のためのナノ構造化ゲルの製剤
JP2022080798A JP2022103299A (ja) 2017-05-08 2022-05-17 増大した薬剤負荷および接着のためのナノ構造化ゲルの製剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022080798A Division JP2022103299A (ja) 2017-05-08 2022-05-17 増大した薬剤負荷および接着のためのナノ構造化ゲルの製剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023173522A Division JP2023168587A (ja) 2017-05-08 2023-10-05 増大した薬剤負荷および接着のためのナノ構造化ゲルの製剤

Publications (2)

Publication Number Publication Date
JP2023041861A JP2023041861A (ja) 2023-03-24
JP2023041861A5 true JP2023041861A5 (https=) 2023-10-16

Family

ID=62223333

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2019562349A Active JP7211974B2 (ja) 2017-05-08 2018-05-08 増大した薬剤負荷および接着のためのナノ構造化ゲルの製剤
JP2022080798A Pending JP2022103299A (ja) 2017-05-08 2022-05-17 増大した薬剤負荷および接着のためのナノ構造化ゲルの製剤
JP2023014533A Pending JP2023041861A (ja) 2017-05-08 2023-02-02 増大した薬剤負荷および接着のためのナノ構造化ゲルの製剤
JP2023173522A Pending JP2023168587A (ja) 2017-05-08 2023-10-05 増大した薬剤負荷および接着のためのナノ構造化ゲルの製剤

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2019562349A Active JP7211974B2 (ja) 2017-05-08 2018-05-08 増大した薬剤負荷および接着のためのナノ構造化ゲルの製剤
JP2022080798A Pending JP2022103299A (ja) 2017-05-08 2022-05-17 増大した薬剤負荷および接着のためのナノ構造化ゲルの製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023173522A Pending JP2023168587A (ja) 2017-05-08 2023-10-05 増大した薬剤負荷および接着のためのナノ構造化ゲルの製剤

Country Status (6)

Country Link
US (2) US10881745B2 (https=)
EP (1) EP3621594A1 (https=)
JP (4) JP7211974B2 (https=)
AU (2) AU2018266131B2 (https=)
CA (1) CA3061480A1 (https=)
WO (1) WO2018208822A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3136635A1 (en) * 2019-04-11 2020-10-15 Convatec Technologies Inc. Superporous hydrogels, methods of making the same, and articles incorporating the same
CN111781128B (zh) * 2020-06-15 2023-07-07 迪瑞医疗科技股份有限公司 一种尿分析仪用鞘液及其制备方法

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2417494A1 (fr) 1978-02-16 1979-09-14 Bottu Nouvelles compositions analgesiques et antipyretiques contenant un derive de paracetamol
AU653026B2 (en) 1991-06-07 1994-09-15 Teikoku Seiyaku Kabushiki Kaisha Physiologically active polypeptide-containing pharmaceutical composition
GB9403857D0 (en) 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
ATE221086T1 (de) * 1995-11-15 2002-08-15 Seikagaku Kogyo Co Ltd Photovernetztes hyaluronsäuregel und verfahren zu dessen herstellung
CA2212300A1 (en) 1997-08-04 1999-02-04 Abdellatif Chenite In vitro or in vivo gelfying chitosan and therapeutic uses thereof
BE1011899A6 (fr) 1998-04-30 2000-02-01 Ucb Sa Compositions pharmaceutiques gelifiables utilisables.
FR2794998B1 (fr) 1999-06-21 2001-07-27 Oreal Organogels et leurs utilisations notamment cosmetiques
US7179784B2 (en) 2001-07-10 2007-02-20 Massachusetts Institute Of Technology Surfactant peptide nanostructures, and uses thereof
US20050084470A1 (en) 2003-10-15 2005-04-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Skin care and cleansing compositions containing oil seed product
DE602004031301D1 (de) 2003-11-12 2011-03-17 Applied Nanosystems Bv Nichtsymmetrisches geliermittel
US7544661B2 (en) 2003-12-05 2009-06-09 Northwestern University Self-assembling peptide amphiphiles and related methods for growth factor delivery
WO2005097828A2 (en) * 2004-04-01 2005-10-20 Board Of Regents, The University Of Texas System Peptides of cav2.2 that inhibit pain
DE602005010424D1 (de) 2004-06-03 2008-11-27 Bracco Research Sa Liposomale anordnung für die therapeutische und/oder diagnostische anwendung
FR2871701B1 (fr) 2004-06-21 2006-09-22 Centre Nat Rech Scient Cnrse Biomateriaux bioactifs pour le relarguage controle de principes actifs
US7854943B2 (en) * 2004-06-24 2010-12-21 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
US20080038316A1 (en) 2004-10-01 2008-02-14 Wong Vernon G Conveniently implantable sustained release drug compositions
EP1800694A1 (en) 2005-12-23 2007-06-27 Applied NanoSystems B.V. Controlled release gels
US7988883B2 (en) * 2006-02-10 2011-08-02 Dupont Tate & Lyle Bio Products Company, Llc Heat transfer compositions comprising renewably-based biodegradable 1,3-propanediol
WO2007095255A2 (en) * 2006-02-10 2007-08-23 Dupont Tate & Lyle Bio Products Company, Llc Biodegradable compositions comprising renewably-based, biodegradable 1.3-propanediol
US8968784B2 (en) 2006-05-22 2015-03-03 Research Foundation Of The City University Of New York Method for preparing hydro/organo gelators from disaccharide sugars by biocatalysis and their use in enzyme-triggered drug delivery
US20080021068A1 (en) * 2006-07-24 2008-01-24 Akorn, Inc. Aqueous gel formulation and method for inducing topical anesthesia
JP5358574B2 (ja) 2007-08-17 2013-12-04 アルション セラピューティクス， インコーポレイテッド 高濃度の局所麻酔薬調合物
US8329220B2 (en) 2007-08-24 2012-12-11 Aegis Therapeutics, Llc Controlled release formulations
US20090263489A1 (en) * 2008-04-18 2009-10-22 Warsaw Orthopedic, Inc. Analgesic and anti-inflammatory compositions and methods for reducing, preventing or treating pain and inflammation
WO2010033726A2 (en) 2008-09-17 2010-03-25 The Brigham And Women's Hospital, Inc. Drug delivery composition comprising a self-assembled gelator
JP5724108B2 (ja) * 2009-04-22 2015-05-27 メドスキン ソリューションズ ドクター ズベラック アーゲーＭｅｄＳｋｉｎ Ｓｏｌｕｔｉｏｎｓ Ｄｒ．Ｓｕｗｅｌａｃｋ ＡＧ 凍結乾燥組成物
AU2015200633A1 (en) * 2009-05-04 2015-02-26 Zars Pharma, Inc. Methods for treating pains associated with neuroma, nerve entrapment, and other conditions
CA2770490C (en) * 2009-08-11 2024-04-16 The Johns Hopkins University Compositions and methods for implantation of processed adipose tissue and processed adipose tissue products
US9693976B2 (en) * 2010-01-14 2017-07-04 Crescita Therapeutics Inc. Solid-forming local anesthetic formulations for pain control
EP2361640A1 (en) 2010-02-25 2011-08-31 Université de Liège Cell cultivation in chitosan alginate hydrogel beads
KR20130080435A (ko) * 2010-04-01 2013-07-12 파마네스트 아베 국소마취의 생체 점착성 조성물
BR112013008697A2 (pt) * 2010-09-24 2016-06-21 Massachusetts Inst Technology géis nanoestruturados capazes de liberação controlada de agentes encapsulados
GB201020193D0 (en) 2010-11-29 2011-01-12 Biotec Pharmacon Asa Glucan compositions
ES2390428B1 (es) * 2011-04-15 2013-10-01 Universidad De Almería Preparado de bacterias probióticas para su administración oral a peces cultivados basado en la encapsulación en hidrogeles de alginato.
JP6274440B2 (ja) 2012-06-25 2018-02-07 日産化学工業株式会社 分散液及びヒドロゲル形成方法
US20150246065A1 (en) 2012-09-14 2015-09-03 Cipla Limited Topical Pharmaceutical Composition
WO2014089472A1 (en) 2012-12-07 2014-06-12 Kansas State University Research Foundation Peptide-albumin hydrogel properties and its applications
HK1218858A1 (zh) 2013-03-14 2017-03-17 麻省理工学院 用於长时间持续释放人类抗体的多层可注射自组装肽脚手架水凝胶
US9789073B2 (en) * 2013-03-14 2017-10-17 Pathak Holdings, Llc Compositions, methods and devices for local drug delivery
US20150297731A1 (en) * 2014-04-21 2015-10-22 National Yang-Ming University Thermosensitive injectable glaucoma drug carrier gel and the fabricating method thereof
US9452178B1 (en) * 2014-10-22 2016-09-27 SatisPharma, LLC Acne formulations, treatments, and pressure sensitive patches for delivery of acne formulations
WO2016098057A1 (en) * 2014-12-17 2016-06-23 Socovar, L.P. Chitosan-based hydrogel and applications thereof
EP4279064A3 (en) * 2015-05-12 2024-02-28 Incept, LLC Drug delivery from hydrogels
US9962339B2 (en) * 2015-10-08 2018-05-08 The Brigham And Women's Hospital, Inc. Stabilized assembled nanostructures for delivery of encapsulated agents
EP3452094B1 (en) * 2016-05-06 2021-11-17 The Brigham and Women's Hospital, Inc. Binary self assembled gels for controlled delivery of encapsulated agents to cartilage
CA3062885C (en) * 2016-05-06 2022-03-29 The Brigham And Women's Hospital, Inc. Self-assembled gels for controlled delivery of biologics and labile agents
US20180050055A1 (en) * 2016-08-16 2018-02-22 Hafiz Ahmed Exploiting nutrient deprivation for modulation of glycosylation - research diagnostic, therapeutic, and biotechnology applications
EP3335695B1 (en) * 2016-12-15 2020-02-05 UPM-Kymmene Corporation A method for freeze-drying hydrogel comprising nanofibrillar cellulose, a freeze-dried medical hydrogel comprising nanofibrillar cellulose, and a hydrogel comprising nanofibrillar cellulose

Similar Documents

Publication Publication Date Title
JP2023041861A5 (https=)
Zhang et al. An injectable dipeptide–fullerene supramolecular hydrogel for photodynamic antibacterial therapy
Mashayekhi et al. Curcumin-loaded mesoporous silica nanoparticles/nanofiber composites for supporting long-term proliferation and stemness preservation of adipose-derived stem cells
JP2016531913A5 (https=)
WO2016172712A3 (en) Ophthalmic composition
EA201890836A1 (ru) Инъекционные составы нейростероида, содержащие наночастицы
FI3423076T3 (fi) Topikaalisia syklosporiinia sisältäviä formulaatioita ja niiden käyttöjä
CN113244409A (zh) 一种具有清除活性氧及抗炎作用协同增强效果的纳米粒子
EP4076444A4 (en) INDAZOL DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF HERPES VIRUSES
RU2017124983A (ru) Лечение дегенерации сетчатки с использованием клеток-предшественников
JP2019535677A5 (https=)
JP2006524243A5 (https=)
RU2016125313A (ru) Способы лечения ишемического и геморрагического инсульта, повреждения спинного мозга, повреждения черепного нерва, повреждения периферического нерва и нейродегенеративных расстройств или когнитивных нарушений
RU2020131402A (ru) 4-метилдигидропиримидиноновые соединения и их применение в фармацевтике
JP2018199643A5 (https=)
JP2019502719A5 (https=)
JP2017537702A5 (https=)
CN112426533A (zh) 一种纳米碳酸钙载药系统、其制备方法及其应用
JP2012525422A5 (https=)
Rakesh et al. Alginate beads prepared by ionotropic gelation technique: formulation design
DE602006008186D1 (de) Neues imprägnierverfahren einer textiloberfläche
CN108948265A (zh) 一种具有光响应的纳米载体及其制备方法
TWI616210B (zh) 經修飾微氣泡及其製備方法
Xiao et al. Nanomicrosphere sustained-release urokinase systems with antioxidant properties for deep vein thrombosis therapy
Liang et al. The roles of nanocarriers on pigment epithelium-derived factor in the differentiation of human cardiac stem cells